Rockwell Medical Announces Second Quarter 2026 Results

WIXOM, Mich.--(BUSINESS WIRE)--Aug 13, 2026--

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three and six months ended June 30, 2026.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260813588314/en/

"The momentum in our business continues to build. Our second quarter results reflect the outcome of the actions we have taken to strengthen our commercial position, improve operational efficiency, and enhance profitability," said MarkStrobeck, Ph.D., Rockwell Medical’s President and CEO. "We are a fundamentally stronger company today, with a growing customer base, improving margins, a solid cash position, and a clear path toward achieving our 2026 guidance. As we enter the second half of the year, we remain focused on executing our growth strategy, expanding profitability, generating positive cash flow, and delivering long-term value for shareholders."

FINANCIAL HIGHLIGHTS

Net Sales

Gross Profit

Gross Margin

Net Income (Loss)

Adjusted EBITDA

Cash, Cash Equivalents and Investments Available-for-Sale

OPERATING HIGHLIGHTS

2026 GUIDANCE

In 2026, Rockwell Medical continues to focus on growing revenue, improving operational efficiencies, and achieving sustained profitability. The Company is implementing pricing adjustments to better align product value with market dynamics, and is further streamlining and enhancing its operational efficiencies and distribution footprint to generate additional savings. Rockwell Medical reiterates its 2026 annual guidance as follows:

WEBCAST DETAILS

Date: Thursday, August 13, 2026

Time: 8:00 a.m. ET

Webcast and Replay:www.RockwellMed.com/Results

Speakers:

Format: Discussion of second quarter 2026 financial and operational results followed by Q&A.

NON-GAAP FINANCIAL MEASURES

To supplement Rockwell Medical’s unaudited condensed consolidated statements of operations and unaudited condensed consolidated balance sheets, which are prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”), this press release also includes references to Adjusted EBITDA, a non-GAAP financial measure that is defined as net income (loss) before net interest income (expense), net other income (expense), income tax expenses (benefit), depreciation and amortization, impairment charges, stock-based compensation expense, and other items that are considered unusual or not representative of underlying trends of our business, including but not limited to one-time severance costs, deferred revenue and inventory reserve amounts, if applicable for the periods presented. The Company has provided a reconciliation of net loss, the most directly comparable GAAP financial measure, to Adjusted EBITDA. In addition, this press release includes a reference to Adjusted EPS, a non-GAAP financial measure that is defined as Adjusted EBITDA divided by the weighted average number of shares outstanding. The Company has also provided a reconciliation to EPS, or net income divided by the weighted average number of shares outstanding, which is the most directly comparable GAAP financial measure. Each of these adjusted measures is a non-GAAP financial measure. The Company has provided reconciliations to the GAAP measures at the end of this press release.

Adjusted EBITDA and Adjusted EPS are key measures used by Rockwell Medical to understand and evaluate operating performance and trends, to prepare and approve its annual budget and to develop short- and long-term operating plans. The Company provides Adjusted EBITDA because it believes the metric is helpful in highlighting trends in its operating results because it excludes items that are not indicative of Rockwell Medical’s core operating performance. In particular, the Company believes that the exclusion of the items eliminated in calculating Adjusted EBITDA provides useful measures for period-to-period comparisons of Rockwell Medical’s business. This is also true for Adjusted EPS, which is derived from Adjusted EBITDA.

Adjusted EBITDA and Adjusted EPS should not be considered in isolation of, or as an alternative to, measures prepared in accordance with GAAP. Other companies, including companies in the same industry, may calculate similarly titled non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of Adjusted EBITDA and Adjusted EPS as tools for comparison. There are a number of limitations related to the use of these non-GAAP financial measures rather than the most directly comparable financial measure calculated in accordance with GAAP. When evaluating the Company’s performance, you should consider Adjusted EBITDA and Adjusted EPS alongside other financial performance measures, including net loss, EPS and other GAAP results.

ABOUT ROCKWELL MEDICAL

Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is typically performed in freestanding outpatient dialysis centers, hospital-based outpatient centers, skilled nursing facilities, or a patient’s home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Certified as a Great Place to Work ® four years in a row (2023-2026) and named Fortune Best Workplaces in Manufacturing & Production™ in 2024 and 2025, Rockwell Medical is Driven to Deliver Life-Sustaining Dialysis Solutions™. For more information, visit www.rockwellmed.com.

FORWARD-LOOKING STATEMENTS

Certain statements in this press release may constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as, "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "could," "can," "would," "develop," "plan," "potential," "predict," "forecast," "project," "intend," "look forward to," "remain confident," “remain steadfast,” “guidance,” “working to,” “goal” or the negative of these terms, and similar expressions, or statements regarding intent, belief, or current expectations, are forward looking statements. Such statements include without limitation statements relating to: our financial guidance, including projections regarding net sales, gross margin, Adjusted EBITDA and operating cash flow; and our expectations regarding the outcome of our focus on executing our growth strategy, expanding profitability, generating positive cash flow, and delivering long-term value for shareholders. While Rockwell Medical believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties (including, without limitation, those set forth in Rockwell Medical's SEC filings), many of which are beyond our control and subject to change. Actual results could be materially different. Risks and uncertainties include but are not limited to those risks more fully discussed in the "Risk Factors" section of our Annual Report on Form 10-K for the year ended December 31, 2025, as such description may be amended or updated in any subsequent reports filed with the SEC. Rockwell Medical expressly disclaims any obligation to update our forward-looking statements, except as may be required by law.

Financial Tables Follow

 

Rockwell Medical's Profitability Trend (2021-2026)

PERTH, Australia (AP) — An Australian jury on Thursday convicted a former Catholic bishop renowned for hosting alcohol-fueled house parties of sexually abusing two young Indigenous men.

The District Court of Western Australia jury convicted Christopher Saunders, 76, of 13 out of 19 charges of sexual abuse that allegedly occurred between 2008 and 2019 in his sprawling diocese on the country’s tropical northwest coast.

Prosecutors alleged he lured young Indigenous men to his church-owned house in the tourist town of Broome with free alcohol and cigarettes paid for with church funds. House rules included that the male-only guests had to remove their shirts.

“The accused had a sexual interest in young Aboriginal men and a tendency to act on that interest when the opportunity presented itself,” Prosecutor Adam Ebell had told the court.

The convictions included one count of sexual penetration without consent and a dozen indecent assaults.

He was acquitted of six charges that included a third alleged victim and indecent dealing with a child over the age of 16. While the age of consent in the state is 16, the law raises the effective age of consent to 18 if an older person is in a position of trust, power or responsibility.

Four charges of sexual penetration of a child younger than 13 years were dropped on the first day of Saunders' three-week trial.

Saunders is one of the most senior Australian Catholics to be convicted in a global clergy abuse scandal that has besieged the Vatican for years.

Cardinal George Pell was convicted of abusing choirboys, and Archbishop Philip Wilson was convicted of covering up child sex abuse. But both Australian clerics successfully appealed their convictions.

Saunders showed no reaction as the verdicts were announced. He had been free on bail since he was charged two years ago. He did not apply to remain on bail after his convictions and will be sentenced on Sept. 21.

Defense lawyer Tony Hager had told the jurors in his closing address that Saunders did not deny holding “boozy parties” where young men often stripped off their shirts and shorts.

Saunders' behavior had been at times unusual, boozy and “might even be sleazy,” but it was never sexual, Hager argued.

Saunders led the remote Broome Diocese from 1996 until he resigned in 2021. The Outback diocese covers an area larger than France with a population of only 50,000 people. Most of the region’s Catholics are Indigenous.

His resignation followed a police announcement that they had dropped a criminal investigation into sexual allegations against him.

He had stood down from the church governance role a year earlier after news media reported the allegations.

The Vatican began its own investigation into Saunders in 2022, then handed the Western Australia Police Force a 200-page report on its findings the following year. Police reopened the criminal investigation and charged Saunders in 2024.

While the report’s contents were never officially made public, they were leaked to Australia’s Seven Network television news, which reported Saunders likely sexually assaulted four Indigenous youths and potentially groomed another 67 Indigenous youths and men.

The current Bishop of Broome, Tim Norton, issued an apology to Saunders’ victims and the diocese after the verdicts.

“We are acutely aware that the victims of this betrayal are not just those who have told their stories to police and before the court,” Norton said in a statement.

“The hurt extends to those who have placed their trust in our leadership and our church,” Norton added.

A national inquiry into the Catholic Church and other institutions’ responses to child abuse found that 7% of Australian Catholic priests were accused of sexually abusing children between 1950 and 2010.

FILE - Bishop Christopher Saunders of Broome, left, tries to play a didgeridoo during a World Youth Day 2008 media event in Sydney, Australia, on April 17, 2008. (AP Photo/Rob Griffith, File)

Former Bishop of Broome Christopher Saunders arrives at the West Australian District Court in Perth, Tuesday, Aug.11, 2026. (Aaron Bunch/AAP Image via AAP)